These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
439 related items for PubMed ID: 12019079
1. Resistance mechanisms in clinical isolates of Candida albicans. White TC, Holleman S, Dy F, Mirels LF, Stevens DA. Antimicrob Agents Chemother; 2002 Jun; 46(6):1704-13. PubMed ID: 12019079 [Abstract] [Full Text] [Related]
2. Expression of Major Efflux Pumps in Fluconazole-Resistant Candida albicans. Pourakbari B, Teymuri M, Mahmoudi S, Valian SK, Movahedi Z, Eshaghi H, Mamishi S. Infect Disord Drug Targets; 2017 Jun; 17(3):178-184. PubMed ID: 28558643 [Abstract] [Full Text] [Related]
3. Molecular mechanisms associated with Fluconazole resistance in clinical Candida albicans isolates from India. Mane A, Vidhate P, Kusro C, Waman V, Saxena V, Kulkarni-Kale U, Risbud A. Mycoses; 2016 Feb; 59(2):93-100. PubMed ID: 26648048 [Abstract] [Full Text] [Related]
4. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Sanglard D, Kuchler K, Ischer F, Pagani JL, Monod M, Bille J. Antimicrob Agents Chemother; 1995 Nov; 39(11):2378-86. PubMed ID: 8585712 [Abstract] [Full Text] [Related]
5. Molecular mechanisms of fluconazole resistance in Candida dubliniensis isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis. Perea S, López-Ribot JL, Wickes BL, Kirkpatrick WR, Dib OP, Bachmann SP, Keller SM, Martinez M, Patterson TF. Antimicrob Agents Chemother; 2002 Jun; 46(6):1695-703. PubMed ID: 12019078 [Abstract] [Full Text] [Related]
6. Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance. Sanguinetti M, Posteraro B, Fiori B, Ranno S, Torelli R, Fadda G. Antimicrob Agents Chemother; 2005 Feb; 49(2):668-79. PubMed ID: 15673750 [Abstract] [Full Text] [Related]
9. Overexpression and mutation as a genetic mechanism of fluconazole resistance in Candida albicans isolated from human immunodeficiency virus patients in Indonesia. Rosana Y, Yasmon A, Lestari DC. J Med Microbiol; 2015 Sep; 64(9):1046-1052. PubMed ID: 26297039 [Abstract] [Full Text] [Related]
10. Assessment of antifungal resistance and associated molecular mechanism in Candida albicans isolates from different cohorts of patients in North Indian state of Haryana. Kumar A, Nair R, Kumar M, Banerjee A, Chakrabarti A, Rudramurthy SM, Bagga R, Gaur NA, Mondal AK, Prasad R. Folia Microbiol (Praha); 2020 Aug; 65(4):747-754. PubMed ID: 32219719 [Abstract] [Full Text] [Related]
11. The ATP binding cassette transporter gene CgCDR1 from Candida glabrata is involved in the resistance of clinical isolates to azole antifungal agents. Sanglard D, Ischer F, Calabrese D, Majcherczyk PA, Bille J. Antimicrob Agents Chemother; 1999 Nov; 43(11):2753-65. PubMed ID: 10543759 [Abstract] [Full Text] [Related]
12. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms. Sanglard D, Coste AT. Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310 [Abstract] [Full Text] [Related]
13. Mechanisms of resistance to fluconazole in Candida albicans clinical isolates from Iranian HIV-infected patients with oropharyngeal candidiasis. Salari S, Khosravi AR, Mousavi SA, Nikbakht-Brojeni GH. J Mycol Med; 2016 Mar; 26(1):35-41. PubMed ID: 26627124 [Abstract] [Full Text] [Related]
14. Comparison of gene expression profiles of Candida albicans azole-resistant clinical isolates and laboratory strains exposed to drugs inducing multidrug transporters. Karababa M, Coste AT, Rognon B, Bille J, Sanglard D. Antimicrob Agents Chemother; 2004 Aug; 48(8):3064-79. PubMed ID: 15273122 [Abstract] [Full Text] [Related]
15. [Investigation of the expression levels of efflux pumps in fluconazole-resistant Candida albicans isolates]. Gulat S, Doluca Dereli M. Mikrobiyol Bul; 2014 Apr; 48(2):325-34. PubMed ID: 24819270 [Abstract] [Full Text] [Related]
16. Increased expression and hotspot mutations of the multidrug efflux transporter, CDR1 in azole-resistant Candida albicans isolates from vaginitis patients. Looi CY, D' Silva EC, Seow HF, Rosli R, Ng KP, Chong PP. FEMS Microbiol Lett; 2005 Aug 15; 249(2):283-9. PubMed ID: 16006060 [Abstract] [Full Text] [Related]
17. Stepwise emergence of azole, echinocandin and amphotericin B multidrug resistance in vivo in Candida albicans orchestrated by multiple genetic alterations. Jensen RH, Astvad KM, Silva LV, Sanglard D, Jørgensen R, Nielsen KF, Mathiasen EG, Doroudian G, Perlin DS, Arendrup MC. J Antimicrob Chemother; 2015 Sep 15; 70(9):2551-5. PubMed ID: 26017038 [Abstract] [Full Text] [Related]
18. Clonal spread and azole-resistant mechanisms of non-susceptible Candida albicans isolates from vulvovaginal candidiasis patients in three Shanghai maternity hospitals. Wu Y, Li C, Wang Z, Gao J, Tang Z, Chen H, Ying C. Med Mycol; 2018 Aug 01; 56(6):687-694. PubMed ID: 29136186 [Abstract] [Full Text] [Related]
19. Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene. Sanglard D, Ischer F, Monod M, Bille J. Microbiology (Reading); 1997 Feb 01; 143 ( Pt 2)():405-416. PubMed ID: 9043118 [Abstract] [Full Text] [Related]
20. A novel multidrug efflux transporter gene of the major facilitator superfamily from Candida albicans (FLU1) conferring resistance to fluconazole. Calabrese D, Bille J, Sanglard D. Microbiology (Reading); 2000 Nov 01; 146 ( Pt 11)():2743-2754. PubMed ID: 11065353 [Abstract] [Full Text] [Related] Page: [Next] [New Search]